Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer
| Status: | Recruiting |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 25 - Any |
| Updated: | 5/3/2018 |
| Start Date: | March 15, 2018 |
| End Date: | September 2020 |
| Contact: | Eileen Chang |
| Email: | eic2002@med.cornell.edu |
| Phone: | 212-746-6248 |
This is a single institution study enrolling women over age 25 with newly diagnosed breast
cancer and for whom a breast MR has been ordered as standard of care. Subjects will undergo a
hybrid dedicated Breast PET/MRI in lieu of a breast MRI alone, for evaluation of extent of
disease prior to surgical and oncologic management. The study will investigate any
incremental added benefit to breast MRI specificity by the addition of concurrent hybrid
breast PET.
cancer and for whom a breast MR has been ordered as standard of care. Subjects will undergo a
hybrid dedicated Breast PET/MRI in lieu of a breast MRI alone, for evaluation of extent of
disease prior to surgical and oncologic management. The study will investigate any
incremental added benefit to breast MRI specificity by the addition of concurrent hybrid
breast PET.
The study hypothesis is that the combination of Breast PET/MRI, will improve specificity and
decrease the number of false positive breast biopsies recommended based on breast MRI
findings.
decrease the number of false positive breast biopsies recommended based on breast MRI
findings.
Inclusion Criteria:
- Women over age of 25 with newly diagnosed breast cancer and for whom a breast MR has
been ordered as standard of care
Exclusion Criteria:
- Male subjects
- Women younger than 25
- Pregnant subjects
- Unable or unwilling to undergo MRI
- Previous adverse reaction to 18F-FDG
- Unwilling to undergo biopsy of MRI positive lesions
We found this trial at
1
site
Click here to add this to my saved trials
